Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
JMA J ; 7(1): 85-93, 2024 Jan 15.
Article in English | MEDLINE | ID: mdl-38314428

ABSTRACT

Introduction: Cardiovascular disease (CVD) is the leading cause of death in hemodialysis patients (HPs). As a food source, fish contains both CVD-preventive and CVD-promoting fatty acids; however, there is no consensus on fish consumption as a preventive measure for CVD in HPs. This single-center longitudinal cohort study aims to assess the impact of fish intake frequency (FIF) per week on CVD in Japanese HPs. Methods: Upon the initiation of the study, 148 HPs were evaluated to determine the FIF, and blood samples were analyzed. These patients were then monitored for 6 years.The relationships between each FIF and blood sampling data, CVD-specific survival (CSS), and new CVD-free survival (nCFS) were statistically calculated using Kaplan-Meier survival curves. Results: During the observation period, 65 deaths were reported, 16 of which were attributed to CVD. Further, 53 patients developed new CVD onset, and no association was found between the FIF and blood sampling data. Based on the Kaplan-Meier survival curves, there was a significant difference in the CSS probability rates at 72 months between patients with an FIF of ≥4 (0.719, 95% confidence interval (CI): 0.530-0.842) and those with an FIF of ≤3 (0.930, 95% CI: 0.851-0.968) (p < 0.01). However, the nCFS probability at 72 months did not significantly differ between patients with an FIF of ≥4 and those with an FIF of ≤3. Multivariate Cox proportional hazards regression showed that an FIF of ≥4 (hazard ratio: 3.64, 95% CI: 1.22-10.9, p = 0.02) was an independent predictor of CSS, but not of nCFS. Conclusions: It was suggested that a higher FIF in HPs might be one of the risks for developing CVD with increased mortality.

2.
Plant Physiol Biochem ; 173: 14-24, 2022 Jan 15.
Article in English | MEDLINE | ID: mdl-35091187

ABSTRACT

In the present study, we studied the effects of gibberellic acid (GA) on chlorophyll and carotenoid metabolites and related gene expression during the regreening process in Valencia orange fruits (Citrus sinensis Osbeck). During the regreening, fruits treated with GA turned green much faster than those of the control. Compared with untreated fruits, chlorophyll accumulation was induced and the content of carotenoids (ß-cryptoxanthin, all-trans-violaxanthin, and 9-cis-violaxanthin) was decreased by the GA treatment. Chlorophyll and carotenoid contents following GA treatment appeared to be highly regulated at the gene transcription level. Correspondingly, the up-regulation of chlorophyll biosynthesis genes (CitGGDR, CitCHL27, CitPORA, and CitCAO) and down-regulation of degradation genes (CitCLH1, CitSGR, CitPPH, CitPAO, and CitRCCR) led to the increase of chlorophyll contents, and the down-regulation of carotenoid biosynthesis genes (CitPSY, CitPDS, CitZDS, CitLCYb2, and CitHYb) led to the decrease of carotenoid contents. These observations indicated that GA acted as a crucial regulator in the regreening process of citrus fruits.


Subject(s)
Citrus sinensis , Citrus , Carotenoids , Chlorophyll , Citrus/metabolism , Fruit/metabolism , Gene Expression Regulation, Plant , Gibberellins , Plant Proteins/genetics , Plant Proteins/metabolism
3.
Urol Case Rep ; 29: 101099, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31908961

ABSTRACT

Small cell carcinoma in the ureter is extremely rare, with few cases reported in the literature. The current report describes the case of a 63-year-old man who presented with right-side back pain. A mass was identified in the right ureter. A nephroureterectomy was performed. Subsequent microscopic examination revealed that the mass comprised a monotonous population of small cells and that the carcinoma cells were positive for cluster of AE1/AE3 and synaptophysin. The tumor was diagnosed as a ureteral small cell carcinoma. Adjuvant chemotherapy was administered with 80 mg/m2 intravenous cisplatin on day 1 and 100 mg/m2 etoposide on days 1-3, every 21 days for 2 cycles. The patient has remained disease-free 6 months after surgery.

SELECTION OF CITATIONS
SEARCH DETAIL
...